Mach7 Technologies Limited (ASX: M7T) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Mach7 Technologies Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Mach7 Technologies Limited (ASX: M7T)
Latest News
Speculative
Could these exciting ASX shares be future stars?
Speculative
2 exciting small cap ASX shares to watch
Share Market News
3 quarterly updates you might have missed: Alcidion, Mach7, & Telix
Speculative
3 exciting small cap ASX shares to watch in August
Speculative
3 exciting small cap ASX shares to watch in FY 2021
Speculative
Add these ASX small cap shares to your watchlist immediately
Speculative
5 exciting small cap ASX shares to watch
Speculative
Why you should watch these exciting small cap ASX healthcare shares closely
Speculative
3 exciting small cap ASX shares to add to your watchlist
52-Week Highs
Why ResMed and these ASX shares have just hit new highs
Share Market News
Fund managers have been buying these ASX shares
Speculative
3 exciting small cap ASX healthcare shares to watch
Frequently Asked Questions
-
No, this ASX small-cap share has never paid dividends.
-
Mach7 Technologies has been listed on the ASX since 30 November 2005.
M7T ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Mach7 Technologies Limited
Mach7 Technologies Ltd (ASX: M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. Its systems create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. This allows healthcare enterprises to identify, connect, and share diagnostic image and patient care intelligence.
Mach7 has more than 150 customers in 15 countries and derives a majority of its revenue from North America.
